Kangmei Pharmaceutical Co Ltd Tangible Net Worth Ratio

Latest as of September 2025: 94.6%

Kangmei Pharmaceutical Co Ltd tangible net worth ratio. Kangmei Pharmaceutical Co Ltd (600518) has a Tangible Net Worth Ratio of 94.6% as of September 2025. This metric is calculated by deducting intangible assets (CN¥391.48 Million) from net assets (CN¥7.22 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Kangmei Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.

Tangible NW Ratio

94.6%
Tangible equity / total equity

Net Assets (Equity)

CN¥7.22 Billion
CNY

Intangible Assets

CN¥391.48 Million
Goodwill, patents, brand value

Total Assets

CN¥13.68 Billion
CNY

Tangible Net Worth Ratio of Kangmei Pharmaceutical Co Ltd (1997–2024)

Tangible net worth ratio of Kangmei Pharmaceutical Co Ltd from 1997 to 2024. This chart shows how Kangmei Pharmaceutical Co Ltd's Tangible Net Worth Ratio has changed across 27 annual periods from 1997 to 2024. As of September 2025, the ratio stands at 94.6%, reflecting net assets of CN¥7.22 Billion with intangible assets of CN¥391.48 Million CNY. Check 600518 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Kangmei Pharmaceutical Co Ltd Tangible Net Worth Ratio by Year (1997–2024)

Kangmei Pharmaceutical Co Ltd tangible net worth ratio by year from 1997 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Kangmei Pharmaceutical Co Ltd from 1997 to 2024, covering 27 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 600518 company net worth.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2024 94.3% CN¥7.21 Billion CN¥409.47 Million CN¥13.80 Billion ▲ +1.3 pp
2023 93.1% CN¥7.08 Billion CN¥491.02 Million CN¥14.28 Billion ▲ +0.7 pp
2022 92.4% CN¥6.93 Billion CN¥529.79 Million CN¥15.11 Billion ▼ -1.8 pp
2021 94.2% CN¥9.97 Billion CN¥579.73 Million CN¥16.05 Billion ▲ +4.0 pp
2019 90.2% CN¥20.65 Billion CN¥2.03 Billion CN¥64.59 Billion ▼ -1.6 pp
2018 91.8% CN¥26.12 Billion CN¥2.14 Billion CN¥73.14 Billion ▼ -1.2 pp
2017 93.0% CN¥28.52 Billion CN¥1.99 Billion CN¥65.29 Billion ▼ -0.8 pp
2016 93.8% CN¥29.38 Billion CN¥1.83 Billion CN¥54.82 Billion ▼ -0.6 pp
2015 94.4% CN¥18.84 Billion CN¥1.05 Billion CN¥38.11 Billion ▲ +0.8 pp
2014 93.6% CN¥16.72 Billion CN¥1.07 Billion CN¥27.88 Billion ▲ +8.6 pp
2013 85.0% CN¥12.03 Billion CN¥1.80 Billion CN¥22.25 Billion ▲ +2.8 pp
2012 82.3% CN¥10.58 Billion CN¥1.88 Billion CN¥17.96 Billion ▲ +3.4 pp
2011 78.9% CN¥9.25 Billion CN¥1.95 Billion CN¥15.24 Billion ▲ +6.3 pp
2010 72.5% CN¥4.93 Billion CN¥1.35 Billion CN¥8.21 Billion ▼ -7.1 pp
2009 79.6% CN¥4.27 Billion CN¥871.04 Million CN¥6.22 Billion ▼ -2.7 pp
2008 82.3% CN¥2.92 Billion CN¥515.01 Million CN¥4.21 Billion ▼ -12.5 pp
2007 94.8% CN¥2.32 Billion CN¥119.52 Million CN¥3.20 Billion ▲ +0.9 pp
2006 94.0% CN¥1.16 Billion CN¥69.71 Million CN¥1.92 Billion ▲ +15.5 pp
2005 78.5% CN¥573.59 Million CN¥123.23 Million CN¥790.04 Million ▲ +3.5 pp
2004 75.0% CN¥511.88 Million CN¥128.01 Million CN¥853.97 Million ▼ -11.3 pp
2003 86.3% CN¥442.44 Million CN¥60.83 Million CN¥704.69 Million ▲ +2.6 pp
2002 83.7% CN¥391.23 Million CN¥63.94 Million CN¥629.58 Million ▼ -10.2 pp
2001 93.9% CN¥365.10 Million CN¥22.26 Million CN¥517.61 Million ▲ +18.1 pp
2000 75.8% CN¥103.96 Million CN¥25.19 Million CN¥231.23 Million ▼ -5.0 pp
1999 80.7% CN¥111.12 Million CN¥21.40 Million CN¥226.89 Million ▲ +4.1 pp
1998 76.6% CN¥77.20 Million CN¥18.07 Million CN¥208.33 Million ▲ +7.0 pp
1997 69.6% CN¥63.54 Million CN¥19.32 Million CN¥177.12 Million —
pp = percentage points